The Myklebost group arranged a succesful workshop for the EU "Network of Excellence on Bone Tumours", Research Line 2: "Osteogenic tumours and related sarcomas", in which they are Work Package Leaders. Thirty participants from ten European countries - including several clinicians from the National Competence Centre for Sarcomas - discussed progress and plans during a two-day meeting held June 10-12th at Lysebu Conference Centre.
Naolou T, Schadzek N, Pepelanova I, Frommer M, Hornbostel JM, Lötz F, Sauheitl L, Dultz S, Felde VJMNL, Myklebost O, Lee-Thedieck C(2025) Enhanced gelatin methacryloyl nanohydroxyapatite hydrogel for high-fidelity 3D printing of bone tissue engineering scaffolds Biofabrication(in press) DOI 10.1088/1758-5090/adbb90, PubMed 40020249
Song L, Kostas M, Laerdahl JK, Skálová M, Janská T, Juzeniene A, Ræstad S, Krivokapic A, Kalantzopoulos GN, Soltes J, Vlk M, Kozempel J, Hassfjell S, Wesche J(2025) Preparation and Characterization of an Engineered FGF1 Conjugated to 161Tb for Targeting of FGFRs ACS Omega, 10(6), 5730-5743 DOI 10.1021/acsomega.4c09179, PubMed 39989790
Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W, Lorenz S, Lawrence MS, Myklebost O, Kimby E, Pan-Hammarström Q, Steen CB, Meza-Zepeda LA, Beiske K, Smeland EB, Hovig E, Lingjærde OC, Holte H, Myklebust JH(2024) Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma Blood Cancer J, 14(1), 147 DOI 10.1038/s41408-024-01124-5, PubMed 39191762